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Symposium: Creating Stem Cells by Research 
Cloning: Scientific, Ethical, Legal & Policy 
Challenges 
Introduction 
Jeffrey Kahn* 
The following collection of articles represents the product 
of a day-long conference held at the University of Minnesota 
entitled Creating Stem Cells by Research Cloning: Scientific, 
Ethical, Legal & Policy Challenges.  The conference was hosted 
by the Consortium on Law and Values in Health, Environment 
& the Life Sciences; the Joint Degree Program in Law, Health 
& the Life Sciences; the Academic Health Center; and the Stem 
Cell Institute at the University of Minnesota.  This conference 
highlighted the science, ethics, law, and policy issues related to 
the creation of human embryonic stem cells by somatic cell 
nuclear transfer (SCNT), a technique often colloquially referred 
to as research cloning or therapeutic cloning.  The conference 
was organized in an effort to offer analysis of the latest cutting-
edge science, as well as a forum for dispassionate discussion of 
one of the most heated policy debates in decades.  As a matter 
of disclosure, the conference was funded entirely by University 
funds and sought to include not only speakers with the most 
current knowledge about the science and implications of SCNT 
research, but speakers representing a range of views across the 
admittedly broad spectrum of thought on the ethical and policy 
issues on the topic.  Full video and conference information is 
available at http://lifesci.consortium.umn.edu/conferences/ 
scnt.php.  All views expressed in the symposium articles 
resulting from the conference are those of the authors. 
In addition to this introduction, the collection of articles in 
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Research cloning of embryos is itself controversial, as many 
people believe the intention for which embryos are created is 
critically important in thinking about the ethics of their use. 
On this view, using embryos that were created in fertility 
clinics—originally intended for use in reproduction—is more 
acceptable than creating embryos expressly for the purpose of 
research, and creating embryos expressly for research purposes 
(whether by in vitro fertilization or SCNT) does not treat them 
with adequate respect.  But for others, the moral costs of 
this issue of MJLST is made up of a colloquy among three 
discussants and two full-length articles.  The colloquy presents 
the remarks offered by three commentators: Dr. Frank Cerra, 
the University’s Sr. Vice President for the Health Sciences and 
McKnight Presidential Leadership Chair at the Academic 
Health Center, who opened the conference; and two 
participants in the roundtable discussion that concluded the 
conference, Prof. Bryan Dowd, Professor and Director of the 
Graduate Programs in Health Policy and Management in the 
University’s School of Public Health, and Prof. Dan Kaufman, a 
McKnight Land-Grant Professor and Assistant Professor of 
Medicine with the University’s Stem Cell Institute.  The two 
full-length articles are by the two plenary speakers from the 
portion of the conference entitled The Ethics of SCNT: Prof. 
Ronald Green from Dartmouth University (“Five Ethical 
Questions for Stem Cell Research”) and Prof. Nigel Cameron 
from the Institute on Biotechnology and the Human Future at 
the Chicago-Kent College of Law (“Brave New World at the 
General Assembly: The United Nations Declaration on Human 
Cloning”) writing with colleague Anna Henderson. 
As Prof. Green summarizes in his article, in late 2001 a 
biotechnology company called Advanced Cell Technology (ACT) 
reported success in their efforts to clone a human embryo by 
SCNT.  They made clear that their intent was to create 
embryos using this technique only for the purpose of isolating 
stem cells (so-called research cloning) and not for use in 
attempts to produce a cloned human being (so-called 
reproductive cloning).  But the announcement of a successfully 
cloned human embryo, even for research purposes, rekindled 
the fear that cloning identical copies of humans cannot be far 
off.  This technical reality was then and remains a distant 
prospect, but the successful cloning of embryos was viewed as 
another step along the path. 
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creating early stage embryos exclusively for research purposes 
are outweighed by the promise of significant medical benefits.  
While therapeutic cloning is morally very different from trying 
to create an identical copy of a human through reproductive 
cloning, as we heard throughout the conference, the techniques 
used to create the embryos would be exactly the same.  In the 
case of reproductive cloning, instead of collecting stem cells 
from the SCNT embryo, doctors would place the cloned embryo 
in a woman’s uterus in the hope that it would result in a 
pregnancy and the birth of a cloned baby.  For some, this 
implies that therapeutic cloning will inevitably lead to 
reproductive cloning.  If the use of SCNT is acceptable, the 
challenge will be to distinguish therapeutic from reproductive 
cloning and create policies that make the distinction stick. 
One attempt has been to craft terms to create distinctions 
for the purpose of policy making.  By calling the therapeutic 
cloning process “nuclear transplantation” or “therapeutic 
cellular transfer,” and the result an “activated egg” or 
“ovasome”—to name a few terms used at the hearings—experts 
in science and ethics, and some politicians, were trying to 
separate the technique from the Brave New World1 future 
conjured by the term “cloning” and to avoid the term “embryo.” 
But do such verbal gymnastics help or hinder public discussion 
and policymaking? 
The purpose of the research performed at ACT and 
elsewhere was to create a source of embryonic stem cells with 
genetic makeup identical to the DNA used to make them.  The 
technique used was exactly the same as with Dolly the sheep, 
which has not been called anything but cloning, and it was part 
of the successful effort to create an embryo.  So if the technique 
used creates an organism that has the same properties as a 
human embryo, can be used in research like human embryos, 
and if implanted in a woman’s uterus would develop like a 
human embryo, then shouldn’t we think about whether to call 
it a human embryo?  To call it something different distracts us 
from the real issues at hand: Should we use human embryos for 
research and therapies, and if so, is it acceptable to make and 
clone them?  As Ronald Green comments in his article, words 
matter.  But clear discussion and debate are even more 
 1.  Nigel M. de S. Cameron & Anna V. Henderson, Brave New World at 
the General Assembly: The United Nations Declaration on Human Cloning, 9 
MINN. J.L. SCI. & TECH. 145 (2008).  
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important.  To that end, the articles and colloquy in this 
collection offer some perspectives on the ethics, law, and policy 
issues in the use of SCNT for the purpose of creating stem cells, 
and on stem cell research more generally. 
Ronald Green’s article outlines five ethical questions for 
SCNT research on stem cells: (1) what is the proper term for 
this research; (2) is it ethically appropriate; (3) what is the 
moral status of the product of SCNT and what should it be 
called (“embryo” or something different); (4) is it ethical to pay 
women as egg donors; and (5) can SCNT as a technique be 
altered to reduce the moral qualms about it?2  Green gives his 
clear answers to all these questions—it will be up to the reader 
to assess whether they are convincing. 
In their article, Nigel Cameron and Anna Henderson give a 
thorough account of the process by which the U.N. General 
Assembly first considered the issues and then issued a 
declaration on the use of SCNT.  The article is a valuable 
resource about an important international policy process that 
received little attention.  Cameron and Henderson contend that 
this relative lack of attention has “hampered efforts to 
depoliticize the domestic debate about cloning,” which has been 
“too readily framed in terms of wider science policy and ethics 
issues, and little placed in a global context.”3  It is not clear 
that greater attention to U.N. Declarations will solve domestic 
debates on this or other issues, but additional thoughtful 
analysis that advances public discussion can certainly help. 
To that end, this collection ends with remarks from three 
commentators organized into a colloquy.4  Dr. Frank Cerra, the 
University’s Sr. Vice President for the Health Sciences, 
comments on the importance of universities as the place for 
controversial research such as SCNT, and for the dialogue that 
must take place so that such research can be dealt with 
transparently and with appropriate scrutiny.5  The pieces in 
 2.  Ronald M. Green, Five Ethical Questions for SCNT Stem Cell 
Research, 9 MINN. J.L. SCI. & TECH. 131 (2008).  
 3. Cameron, supra note 1, at 199. 
 4.  Colloquy, Scientific, Ethical and Policy Challenges for Public 
Universities Engaging in Stem Cell Research, 9 MINN. J.L. SCI. & TECH. 239 
(2008).  
 5.  Frank B. Cerra, A University of Minnesota Perspective on SCNT 
Research: Past Challenges and Strategy for the Future, 9 MINN. J.L. SCI. & 
TECH. 239 (2008).  
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this collection are an attempt to host just such a dialogue.  In a 
similar vein, Prof. Dan Kaufman contends that universities are 
the best place to develop lifesaving innovations, and that in 
spite of years of research and advancement in the treatment of 
diseases like cancer, cures remain elusive.  Kaufman argues, 
then, that there is a “moral imperative” to engage in stem cell 
research, including SCNT, in order to advance treatments and 
seek new therapies as expeditiously as possible.6  Bryan Dowd 
has a quite different view on the role of science and scientists in 
the debates on SCNT and stem cell research more generally.  
He is concerned that the scientific community not only allows 
misinformation to go uncorrected, but also sometimes issues 
such misinformation: “[i]f the scientific establishment is 
engaged in the propagation of fairy tales rather than telling the 
truth then the public is justified in withdrawing its support for 
specific avenues of research.”7 
These are fair claims to the extent that the scientific 
community is itself part of what many contend is the over-
hyping of the promise of stem cell research.  More problematic 
are Dowd’s claims that scientists ought to stick to science and 
avoid pronouncements regarding the ethics of their research: 
Scientists are free to speak their mind as voting citizens, as amateur 
or in rare cases trained, theologians or ethicists, but when speaking 
as voting citizens, theologians or ethicists, they must drop the mantle 
of science.  If they do not, there are an increasing number of people in 
the public square who will remove it for them—and that is neither 
pretty nor good for the scientific enterprise.8 
The problem with this assertion is that it seems to claim 
that (1) scientific expertise has no bearing on moral arguments, 
and (2) that scientists (or others untrained in ethics or 
theology) have no relevant expertise when it comes to making 
statements about moral issues.  First, good ethics requires good 
facts, so we cannot expect to make good decisions on difficult 
moral issues unless we are well-informed.  This is the follow-on 
to Dowd’s appropriate warning about propagating fairy tales 
rather than the truth.  The most useful facts will come from 
those with the greatest expertise, and in the area of SCNT or 
 6. Dan S. Kaufman, The Role of the University in Promoting Human 
Embryonic Stem Cell Research and Stem Cell Therapies, 9 MINN. J.L. SCI. & 
TECH.  255 (2008).  
 7. Bryan Dowd, Science, Morality and Universities, 9 MINN. J.L. SCI. & 
TECH. 246 2008).  
 8. Id. at 247.  
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other stem cell-related research, that must include the 
scientific community.  Second, in some very real sense we are 
all experts in morality, since we must and do make moral 
decisions every day, whether trained as ethicists or not.  While 
there is much to debate about how humans acquire this moral 
sense, there is not much argument about whether it exists.  If 
this is right, then scientists have just as much claim to making 
moral arguments about science as do politicians or ethicists.  
Professional training in ethics comes in handy in learning how 
to analyze the arguments of others and in strengthening your 
own.  I hope that Dowd’s stated view is not where we end up in 
debates like the one we’re having on SCNT, lest we find 
ourselves on the wrong end of Einstein’s famous line, “[s]cience 
without religion is lame, religion without science is blind.”9  
Indeed, we need what Prof. Dowd suggests in the conclusion to 
his remarks: “a brighter future of increased public respect and 
support for a scientific community that values rigor, honesty 
and clarity over political and economic gain and even cultural 
authority.”10  This is a future that we can all endorse. 
 
 9. Albert Einstein, Science and Religion, in SCIENCE PHILOSOPHY AND 
RELIGION: A SYMPOSIUM 209, 211 (1941). 
 10. Dowd, supra note 7, at 251. 
